TUMOR MICROENVIRONMENT IN ESOPHAGEAL ADENOCARCINOMA: CD80 EXPRESSION PEAKS IN EARLY STAGES, IT IS ENHANCED BY NEOADJUVANT THERAPY AND IT IS AN ACCURATE PREDICTOR OF SURVIVAL

(1) Oncological Surgery Unit, Veneto Institute Of Oncology (iov-Irccs), Padova, Italy

(2) Dept Molecular Medicine, University Of Padova, Padova, Italy



This item was part of the Clinical and molecular factors in oesophago-gastric cancer outcomes session at UEG Week 2014

This item can be cited as: United European Gastroenterology Journal; 2014: 2 (Supplement 1)